Hepatic Steatosis Index and Chronic Kidney Disease among Middle-Aged Individuals: A Large-Scale Study in Japan

Table 4

Odds ratios and their 95% confidence intervals for chronic kidney disease in the group with different levels of hepatic steatosis index by sex.

	Total ()	CKD ( (%))	Crude	Adjusted
			OR (95% CI)	OR (95% CI)
Men ()
Q4 ()	16,196	1,804 (11.1)	2.33 (2.14-2.54)	2.28 (2.08-2.49)
Q3 ()	16,243	1,377 (8.5)	1.72 (1.58-1.88)	1.57 (1.43-1.72)
Q2 ()	16,906	1,219 (7.2)	1.45 (1.32-1.58)	1.36 (1.24-1.49)
Q1 ()	16,505	842 (5.1)	1.00	1.00
			for	for
Women ()
Q4 ()	7,326	1,026 (14.0)	2.62 (2.33-2.95)	2.35 (2.08-2.65)
Q3 ()	7,101	706 (9.9)	1.78 (1.57-2.01)	1.61 (1.42-1.83)
Q2 ()	7,289	507 (7.0)	1.20 (1.05-1.37)	1.18 (1.03-1.35)
Q1 ()	7,327	429 (5.9)	1.00	1.00
			for	for

CI: confidence interval; CKD: chronic kidney disease; HSI: hepatic steatosis index; OR: odds ratio; Q1: quartile 1; Q2: quartile 2; Q3: quartile 3; Q4: quartile 4. Adjusted for age, smoking status, alcohol intake, physical activity, hypertension, and dyslipidemia.